Along these lines, Oncomine analyses of the Finak [28] and Richardson [29] datasets demonstrated dramatic reductions of c-Abl expression in invasive carcinomas (Figure 1B), and especially in basal-like breast cancers as compared to their non-basal-like and normal counterparts (Figure 1C). The gene discussed is ABL1; the disease is breast carcinoma.